SRNE Financials
Sorrento Therape - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$385,896
P/E Ratio
-0.0
EPS
$-1.37
Income Statement Highlights
Most Recent Quarter: 2022-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-577.76M
EPS (Diluted)
$-1.37
Balance Sheet Highlights
Total Assets
$472.84M
Total Liabilities
$494.51M
Shareholders Equity
-
Cash & Equivalents
$23.63M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-293.86M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-899.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SRNE revenue?
View SRNE's income statement for detailed revenue data.
Is SRNE profitable?
SRNE reported a loss of $577.76M in the most recent quarter. The net profit margin is -899.0%.
What is SRNE market cap?
SRNE has a market capitalization of $385,896, making it a small-cap stock.
Does SRNE have debt?
View SRNE's balance sheet for debt information.
What is SRNE cash flow?
Cash flow data is available in the full financial statements.